Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care Settings

C. Lionis, M. Anastasaki, A. Bertsias, A. Angelaki, AC. Carlsson, H. Gudjonsdottir, P. Wändell, A. Larrabee Sonderlund, T. Thilsing, J. Søndergaard, B. Seifert, N. Kral, NJ. De Wit, M. Hollander, J. Korevaar, F. Schellevis

. 2020 ; 17 (23) : . [pub] 20201204

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011759

(1) Background: Cardiometabolic diseases are the most common cause of death worldwide. As part of a collaborative European study, this paper aims to explore the implementation of primary care selective-prevention services in five European countries. We assessed the implementation process of the selective-prevention services, participants' cardiometabolic profile and risk and participants' evaluation of the services, in terms of feasibility and impact in promoting a healthy lifestyle. (2) Methods: Eligible participants were primary care patients, 40-65 years of age, without any diagnosis of cardiometabolic disease. Two hundred patients were invited to participate per country. The extent to which participants adopted and completed the implementation of selective-prevention services was recorded. Patient demographics, lifestyle-related cardiometabolic risk factors and opinions on the implementation's feasibility were also collected. (3) Results: Acceptance rates varied from 19.5% (n = 39/200) in Sweden to 100% (n = 200/200) in the Czech Republic. Risk assessment completion rates ranged from 65.4% (n = 70/107) in Greece to 100% (n = 39/39) in Sweden. On a ten-point scale, the median (25-75% quartile) of participant-reported implementation feasibility ranged from 7.4 (6.9-7.8) in Greece to 9.2 (8.2-9.9) in Sweden. Willingness to change lifestyle exceeded 80% in all countries. (4) Conclusions: A substantial variation in the implementation of selective-prevention receptiveness and patient risk profile was observed among countries. Our findings suggest that the design and implementation of behavior change cardiometabolic programmes in each country should be informed by the local context and provide some background evidence towards this direction, which can be even more relevant during the current pandemic period.

000      
00000naa a2200000 a 4500
001      
bmc21011759
003      
CZ-PrNML
005      
20210507102453.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijerph17239080 $2 doi
035    __
$a (PubMed)33291815
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lionis, Christos $u Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
245    10
$a High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care Settings / $c C. Lionis, M. Anastasaki, A. Bertsias, A. Angelaki, AC. Carlsson, H. Gudjonsdottir, P. Wändell, A. Larrabee Sonderlund, T. Thilsing, J. Søndergaard, B. Seifert, N. Kral, NJ. De Wit, M. Hollander, J. Korevaar, F. Schellevis
520    9_
$a (1) Background: Cardiometabolic diseases are the most common cause of death worldwide. As part of a collaborative European study, this paper aims to explore the implementation of primary care selective-prevention services in five European countries. We assessed the implementation process of the selective-prevention services, participants' cardiometabolic profile and risk and participants' evaluation of the services, in terms of feasibility and impact in promoting a healthy lifestyle. (2) Methods: Eligible participants were primary care patients, 40-65 years of age, without any diagnosis of cardiometabolic disease. Two hundred patients were invited to participate per country. The extent to which participants adopted and completed the implementation of selective-prevention services was recorded. Patient demographics, lifestyle-related cardiometabolic risk factors and opinions on the implementation's feasibility were also collected. (3) Results: Acceptance rates varied from 19.5% (n = 39/200) in Sweden to 100% (n = 200/200) in the Czech Republic. Risk assessment completion rates ranged from 65.4% (n = 70/107) in Greece to 100% (n = 39/39) in Sweden. On a ten-point scale, the median (25-75% quartile) of participant-reported implementation feasibility ranged from 7.4 (6.9-7.8) in Greece to 9.2 (8.2-9.9) in Sweden. Willingness to change lifestyle exceeded 80% in all countries. (4) Conclusions: A substantial variation in the implementation of selective-prevention receptiveness and patient risk profile was observed among countries. Our findings suggest that the design and implementation of behavior change cardiometabolic programmes in each country should be informed by the local context and provide some background evidence towards this direction, which can be even more relevant during the current pandemic period.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a kardiovaskulární nemoci $x epidemiologie $x prevence a kontrola $7 D002318
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a primární zdravotní péče $7 D011320
651    _2
$a Česká republika $7 D018153
651    _2
$a Evropa $7 D005060
651    _2
$a Řecko $7 D006115
651    _2
$a Švédsko $x epidemiologie $7 D013548
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Anastasaki, Marilena $u Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
700    1_
$a Bertsias, Antonios $u Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
700    1_
$a Angelaki, Agapi $u Clinic of Social and Family Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece
700    1_
$a Carlsson, Axel C $u Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 14183 Huddinge, Sweden $u Academic Primary Health Care Centre, Stockholm Region, 11365 Stockholm, Sweden
700    1_
$a Gudjonsdottir, Hrafnhildur $u Centre for Epidemiology and Community Medicine, Region Stockholm, 11365 Stockholm, Sweden
700    1_
$a Wändell, Per $u Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 14183 Huddinge, Sweden
700    1_
$a Larrabee Sonderlund, Anders $u Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
700    1_
$a Thilsing, Trine $u Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
700    1_
$a Søndergaard, Jens $u Research Unit of General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense C, Denmark
700    1_
$a Seifert, Bohumil $u Institute of General Practice, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
700    1_
$a Kral, Norbert $u Institute of General Practice, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
700    1_
$a De Wit, Niek J $u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
700    1_
$a Hollander, Monika $u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
700    1_
$a Korevaar, Joke $u Nivel Netherlands Institute for Health Services Research, 3513 CR Utrecht, The Netherlands
700    1_
$a Schellevis, François $u Nivel Netherlands Institute for Health Services Research, 3513 CR Utrecht, The Netherlands $u Department of General Practice, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, location VUmc, 1081 HV Amsterdam, The Netherlands
773    0_
$w MED00176090 $t International journal of environmental research and public health $x 1660-4601 $g Roč. 17, č. 23 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33291815 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102452 $b ABA008
999    __
$a ok $b bmc $g 1650205 $s 1132138
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 17 $c 23 $e 20201204 $i 1660-4601 $m International journal of environmental research and public health $n Int. j. environ. res. public health $x MED00176090
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace